E-LIB Suche - Ergebnisse für: Grover, Natalie S

1

CARs for Hodgkin: engine fine-tuning is in order:

Grover, Natalie S. ; Ramos, Carlos A.
Blood Advances. 8 (2024) 3 - p. 799-801 , 2024

Link: https://doi.org/10.1182/..

2

Race and insurance: real-world insights on CAR-T outcomes:

Ahmed, Nausheen ; Grover, Natalie S.
Blood Advances. 8 (2024) 10 - p. 2589-2591 , 2024

Link: https://doi.org/10.1182/..

3

CD19-directed CART Therapy for T cell/Histiocyte Rich Large..:

Pophali, Priyanka A ; Fein, Joshua A ; Ahn, Kwang Woo...
Blood Advances. , 2024

Link: https://doi.org/10.1182/..

4

Anti-CD30 CAR T cells as consolidation after autologous hae..:

Grover, Natalie S ; Hucks, George ; Riches, Marcie L...
The Lancet Haematology. 11 (2024) 5 - p. e358-e367 , 2024

Link: https://doi.org/10.1016/..

5

Wearable sensor-based performance status assessment in canc..:

Wood, William A. ; Dilip, Deepika ; Derkach, Andriy...
PLOS Digital Health. 2 (2023) 1 - p. e0000178 , 2023

Link: https://doi.org/10.1371/..

6

Impact of diagnosis to treatment interval in patients with ..:

Epperla, Narendranath ; Switchenko, Jeffrey ; Bachanova, Veronika...
Blood Advances. 7 (2023) 11 - p. 2287-2296 , 2023

Link: https://doi.org/10.1182/..

7

Building safety into CAR-T therapy:

Peters, Daniel T. ; Savoldo, Barbara ; Grover, Natalie S.
Human Vaccines & Immunotherapeutics. 19 (2023) 3 - p. , 2023

Link: https://doi.org/10.1080/..

8

Impact of detectable monoclonal protein at diagnosis on out..:

Epperla, Narendranath ; Zhao, Qiuhong ; Karmali, Reem...
Blood Advances. 7 (2023) 17 - p. 5038-5046 , 2023

Link: https://doi.org/10.1182/..

9

Patient-reported outcomes in CD30-directed CAR-T cells agai..:

Tschernia, Nicholas P ; Heiling, Hillary ; Deal, Allison M...
Journal for ImmunoTherapy of Cancer. 11 (2023) 8 - p. e006959 , 2023

Link: https://doi.org/10.1136/..

10

Impact of circulating lymphoma cells at diagnosis on outcom..:

Annunzio, Kaitlin ; Grover, Natalie S. ; Welkie, Rina Li...
Blood Advances. 7 (2023) 22 - p. 6839-6843 , 2023

Link: https://doi.org/10.1182/..

11

A multicenter analysis of the outcomes with venetoclax in p..:

Sawalha, Yazeed ; Goyal, Subir ; Switchenko, Jeffrey M....
Blood Advances. 7 (2023) 13 - p. 2983-2993 , 2023

Link: https://doi.org/10.1182/..

12

Impact of early relapse within 24 months after first-line s..:

Epperla, Narendranath ; Welkie, Rina Li ; Torka, Pallawi...
Journal of Hematology & Oncology. 16 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

13

Cellular Therapies in Chronic Lymphocytic Leukemia and Rich..:

Coombs, Catherine C. ; Easaw, Saumya ; Grover, Natalie S..
Cancers. 15 (2023) 6 - p. 1838 , 2023

Link: https://doi.org/10.3390/..

14

CD30-Directed CAR-T Cells Co-Expressing CCR4 in Relapsed/ R..:

Grover, Natalie S. ; Ivanova, Anastasia ; Moore, Dominic T...
Transplantation and Cellular Therapy. 28 (2022) 3 - p. S54-S55 , 2022

Link: https://doi.org/10.1016/..

15

Allogeneic transplant and CAR-T therapy after autologous tr..:

Hamadani, Mehdi ; Gopal, Ajay K. ; Pasquini, Marcelo...
Blood Advances. 6 (2022) 2 - p. 486-494 , 2022

Link: https://doi.org/10.1182/..